Bear,
how long does it take to complete a safety review?
Getting a data review board completed would be material information, so I assume RVX would release the safety review immediately. That should be independent of 250 MACE events.
I am guessing that once the DSMB is declared as uneventful, the share price will move up. That would be an incremental positive as the safety of the drug can't be an issue anymore. Then, it will be on to whether Apabetalone works as we all hope it will.
Who knows...the DSMB result will be a Christmas present for us?